Published in Nucleic Acids Res on March 15, 1998
A highly efficient ligand-regulated Cre recombinase mouse line shows that LoxP recombination is position dependent. EMBO Rep (2001) 3.67
Rapid generation of inducible mouse mutants. Nucleic Acids Res (2003) 2.77
Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res (2002) 2.14
Molecular neuroanatomy's "Three Gs": a primer. Neuron (2007) 1.91
Altered activity, social behavior, and spatial memory in mice lacking the NTAN1p amidase and the asparagine branch of the N-end rule pathway. Mol Cell Biol (2000) 1.64
The histone 3 lysine 4 methyltransferase, Mll2, is only required briefly in development and spermatogenesis. Epigenetics Chromatin (2009) 1.59
An in vivo function for the transforming Myc protein: elicitation of the angiogenic phenotype. Cell Growth Differ (2000) 1.54
Strategies to achieve conditional gene mutation in mice. Cold Spring Harb Protoc (2014) 1.54
Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. EMBO Rep (2000) 1.44
Postnatal tissue-specific disruption of transcription factor FoxN1 triggers acute thymic atrophy. J Biol Chem (2009) 1.29
Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk. EMBO J (1998) 1.13
New variants of inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits enhanced sensitivity and an expanded range of inducibility. Nucleic Acids Res (2001) 1.09
An efficient system for conditional gene expression in embryonic stem cells and in their in vitro and in vivo differentiated derivatives. Proc Natl Acad Sci U S A (2001) 1.05
Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. Nucleic Acids Res (2010) 1.00
Inducible expression based on regulated recombination: a single vector strategy for stable expression in cultured cells. Nucleic Acids Res (1998) 0.93
Optimized adeno-associated virus 8 produces hepatocyte-specific Cre-mediated recombination without toxicity or affecting liver regeneration. Am J Physiol Gastrointest Liver Physiol (2008) 0.91
Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2. Am J Physiol Renal Physiol (2007) 0.91
Cardiac-specific inducible and conditional gene targeting in mice. Circ Res (2012) 0.88
Transgenic mouse technology in skin biology: inducible gene knockout in mice. J Invest Dermatol (2014) 0.88
Essentials of recombinase-based genetic fate mapping in mice. Methods Mol Biol (2014) 0.86
A tamoxifen inducible knock-in allele for investigation of E2A function. BMC Dev Biol (2009) 0.86
The B-cell antigen receptor integrates adaptive and innate immune signals. Proc Natl Acad Sci U S A (2015) 0.80
Impact of conditional deletion of the pro-apoptotic BCL-2 family member BIM in mice. Cell Death Dis (2014) 0.78
Fate tracing of neurogenin2-expressing cells in the mouse retina using CreER™: LacZ. Methods Mol Biol (2012) 0.75
New inducible genetic method reveals critical roles of GABA in the control of feeding and metabolism. Proc Natl Acad Sci U S A (2016) 0.75
Optimizing tamoxifen-inducible Cre/loxp system to reduce tamoxifen effect on bone turnover in long bones of young mice. Bone (2015) 0.75
Inducible gene targeting in mice. Science (1995) 21.22
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science (1994) 13.47
Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19
Subregion- and cell type-restricted gene knockout in mouse brain. Cell (1996) 8.02
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A (1996) 6.48
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell (1988) 4.15
Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res (1996) 3.37
T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci U S A (1995) 3.21
Site-specific recombinases: tools for genome engineering. Trends Genet (1993) 3.18
Epidermal cell fate determination in Arabidopsis: patterns defined by a steroid-inducible regulator. Science (1994) 2.65
Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol (1993) 2.37
Ligand-regulated site-specific recombination. Proc Natl Acad Sci U S A (1995) 2.14
Regulation of Cre recombinase activity by the synthetic steroid RU 486. Nucleic Acids Res (1996) 1.91
Mouse models of human disease. Part I: techniques and resources for genetic analysis in mice. Genes Dev (1997) 1.81
Genome engineering: the new mouse genetics. Nat Med (1995) 1.69
N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J (1989) 1.65
Regulation of protein function through expression of chimaeric proteins. Curr Opin Biotechnol (1994) 1.54
Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res (1996) 1.25
Animal and plant cell lysates share a conserved chaperone system that assembles the glucocorticoid receptor into a functional heterocomplex with hsp90. Biochemistry (1996) 1.03
Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains. J Immunol Methods (1997) 1.01
FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists. Mol Endocrinol (1997) 0.94
The effects of the antihormones RU486 and tamoxifen on fetoplacental development and placental bed vascularisation in the rat: a model for intrauterine fetal growth retardation. Br J Obstet Gynaecol (1996) 0.80
Interleukin-10-deficient mice develop chronic enterocolitis. Cell (1993) 22.57
Inducible gene targeting in mice. Science (1995) 21.22
A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56
A new logic for DNA engineering using recombination in Escherichia coli. Nat Genet (1998) 15.27
Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science (1994) 13.47
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 12.21
High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet (2000) 11.80
Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell (1993) 11.76
Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a gamma 2a variable region. Cell (1981) 9.54
Generation and analysis of interleukin-4 deficient mice. Science (1991) 8.80
Intraclonal generation of antibody mutants in germinal centres. Nature (1991) 7.39
In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell (1997) 7.18
The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci (1995) 6.97
Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res (1999) 6.85
The requirement of more than one antigenic determinant for immunogenicity. J Exp Med (1969) 5.61
B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res (1997) 5.43
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J (2001) 5.34
Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A (1995) 5.06
Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature (1996) 4.95
Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol (1975) 4.79
DNA cloning by homologous recombination in Escherichia coli. Nat Biotechnol (2000) 4.75
Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat Biotechnol (1998) 4.14
Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature (1995) 4.10
Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity (2001) 4.09
Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J (1993) 3.85
Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 3.84
Targeted disruption of mu chain membrane exon causes loss of heavy-chain allelic exclusion. Nature (1992) 3.82
Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell (1999) 3.76
Ku80 is required for immunoglobulin isotype switching. EMBO J (1998) 3.67
NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol Cell (2000) 3.60
The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB. Trends Biochem Sci (1996) 3.55
Most peripheral B cells in mice are ligand selected. J Exp Med (1991) 3.50
Analysis of the repertoire of anti-NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response. Eur J Immunol (1978) 3.48
Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Nature (1978) 3.45
Contribution of receptor editing to the antibody repertoire. Science (2001) 3.45
Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest (1995) 3.43
Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med (1998) 3.37
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology (1999) 3.25
MHC class I expression in mice lacking the proteasome subunit LMP-7. Science (1994) 3.17
Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med (1980) 3.15
Maintenance of B-cell memory by long-lived cells generated from proliferating precursors. Nature (1990) 3.14
Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature (1996) 3.11
A critical role of lambda 5 protein in B cell development. Cell (1992) 3.09
Aberrant B cell development and immune response in mice with a compromised BCR complex. Science (1996) 3.01
Shutdown of class switch recombination by deletion of a switch region control element. Science (1993) 2.99
Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92
Cellular origin of human B-cell lymphomas. N Engl J Med (1999) 2.91
Memory B-cell persistence is independent of persisting immunizing antigen. Nature (2000) 2.90
Analysis of the repertoire of anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti-idiotope antibodies. Eur J Immunol (1979) 2.87
A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (1995) 2.84
Antibody engineering for the analysis of affinity maturation of an anti-hapten response. EMBO J (1988) 2.81
Techniques: Recombinogenic engineering--new options for cloning and manipulating DNA. Trends Biochem Sci (2001) 2.79
Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature (1995) 2.78
Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med (1990) 2.76
The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev (2001) 2.76
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci U S A (1998) 2.76
Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med (1996) 2.75
DNA hypomethylation perturbs the function and survival of CNS neurons in postnatal animals. J Neurosci (2001) 2.75
The half-lives of serum immunoglobulins in adult mice. Eur J Immunol (1988) 2.73
A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann Neurol (1999) 2.73
Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood (1997) 2.64
Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol (1987) 2.60
The chromo shadow domain, a second chromo domain in heterochromatin-binding protein 1, HP1. Nucleic Acids Res (1995) 2.59
Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med (2001) 2.57
Antigen receptors of T helper cells. Contemp Top Immunobiol (1977) 2.54
PCR-based cDNA library construction: general cDNA libraries at the level of a few cells. Nucleic Acids Res (1989) 2.48
Analysis of somatic mutation and class switching in naive and memory B cells generating adoptive primary and secondary responses. Cell (1987) 2.47
Recognition of idiotypes in lymphocyte interactions. II. Antigen-independent cooperation between T and B lymphocytes that possess similar and complementary idiotypes. Eur J Immunol (1978) 2.47
The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow. Proc Natl Acad Sci U S A (1990) 2.47
Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A (1994) 2.41
B cell development under the condition of allelic inclusion. Immunity (1997) 2.39
RecE/RecT and Redalpha/Redbeta initiate double-stranded break repair by specifically interacting with their respective partners. Genes Dev (2000) 2.39
A novel 34-kd protein co-isolated with the IgM molecule in surface IgM-expressing cells. EMBO J (1988) 2.38
Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci U S A (1997) 2.37
Clonal recruitment and somatic mutation in the generation of immunological memory to the hapten NP. EMBO J (1986) 2.35
Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity (1997) 2.35
Efficient and precise engineering of a 200 kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther (1999) 2.32
Stable expression and somatic hypermutation of antibody V regions in B-cell developmental pathways. Annu Rev Immunol (1989) 2.31
Immunoglobulin V region variants in hybridoma cells. II. Recombination between V genes. EMBO J (1982) 2.31
Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem (1987) 2.30
Genetics, expression, and function of idiotypes. Annu Rev Immunol (1983) 2.28
Glucose stimulates human beta cell replication in vivo in islets transplanted into NOD-severe combined immunodeficiency (SCID) mice. Diabetologia (2010) 2.26
Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity (1998) 2.25
Evidence for surface-associated immunoglobulin on T and B lymphocytes. Eur J Immunol (1971) 2.25
Expression and activity of the POU transcription factor SCIP. Science (1990) 2.23
Structure of primary anti-(4-hydroxy-3-nitrophenyl)acetyl (NP) antibodies in normal and idiotypically suppressed C57BL/6 mice. Eur J Immunol (1985) 2.22
Somatic hypermutation in normal and transformed human B cells. Immunol Rev (1998) 2.22
V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science (1997) 2.21
Idiotypic analysis of the response of C57BL/6 mice to the (4-hydroxy-3-nitrophenyl)acetyl group. Eur J Immunol (1977) 2.21
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1988) 2.20
Timing, genetic requirements and functional consequences of somatic hypermutation during B-cell development. Immunol Rev (1987) 2.19
Generation of a mouse strain that produces immunoglobulin kappa chains with human constant regions. Science (1993) 2.19
How alpha beta T cells deal with induced TCR alpha ablation. Proc Natl Acad Sci U S A (2001) 2.19